Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Division of Pathology, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.
Pathol Int. 2020 May;70(5):270-279. doi: 10.1111/pin.12906. Epub 2020 Jan 30.
Intestinal necrosis associated with cation exchange resin (CER) is considered related to sorbitol, but it has been reported even in patients receiving CER alone. This study was performed to identify the risk factors of CER-related intestinal necrosis. The pathological database of 61 end-stage renal disease patients with surgical intervention for intestinal perforation was reviewed. The correlations between CER treatment and clinicopathological factors were studied among three groups: (i) patients administered CER and with CER at the perforation site (n = 23), (ii) patients administered CER with undetected CER at the perforation site (n = 12) and (iii) patients not administered CER (n = 26). The majority of the perforation site in group 1 was in the sigmoid colon (82.6%) with significantly higher average age and more frequent CER adhesion rates to the mucosa around the perforation site than group 2. The laxative administration rate in group 1 was significantly higher than group 3 and tended to be higher than group 2. The incidence of CER-related intestinal necrosis was estimated at 0.57%. CER should be used with extreme caution in elderly patients with passage disturbance.
肠坏死与阳离子交换树脂(CER)有关,被认为与山梨醇有关,但即使在单独使用 CER 的患者中也有报道。本研究旨在确定 CER 相关肠坏死的危险因素。回顾了 61 例因肠穿孔而行手术干预的终末期肾病患者的病理数据库。研究了三组之间 CER 治疗与临床病理因素的相关性:(i)在穿孔部位给予 CER 且 CER 存在于穿孔部位的患者(n=23),(ii)在穿孔部位未检测到 CER 但给予 CER 的患者(n=12),和(iii)未给予 CER 的患者(n=26)。第 1 组的大多数穿孔部位位于乙状结肠(82.6%),其平均年龄明显较高,且 CER 与穿孔部位周围粘膜的粘连率较第 2 组更高。第 1 组的通便剂给药率明显高于第 3 组,且高于第 2 组的趋势。CER 相关肠坏死的发生率估计为 0.57%。对于伴有通道障碍的老年患者,应极其谨慎地使用 CER。